Tisdag 14 Oktober | 14:10:52 Europe / Stockholm

Kalender

Est. tid*
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-02 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2025-05-29 - Årsstämma
2025-04-29 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
2025-09-15 11:41:16

COMPANY ANNOUNCEMENT – No. 2025-17

Copenhagen, Denmark, September 15, 2025 – Brain+ A/S (Nasdaq First North: BRAINP) 

Brain+ A/S (“Brain+” or the “Company”) announces that its Chief Financial Officer (CFO), Hanne Vissing Leth, has decided to pursue a new professional opportunity outside the Company and will step down from her role at the end of October 2025. Brain+ has already initiated a search for her successor to ensure a smooth and seamless transition.

Hanne has been CFO of Brain+ since May 2023, following two years of service as a member of the Board of Directors. She will continue in her role until October 30, 2025, to support the transition process.

The search process for a new CFO has been initiated to identify candidates who can bring the right experience to support Brain+’s continued execution of its UK-focused commercialisation strategy in dementia care. The Company expects to appoint a new CFO in time for an orderly handover.

Devika Wood, CEO of Brain+, commented: “On behalf of the Board and the management team, I want to thank Hanne for her commitment and valuable contributions to Brain+. She has helped strengthen our financial foundation with professionalism, diligence, and a human touch, particularly in guiding the Company through key funding milestones. We wish her every success in her future endeavors, while we also look forward to announcing our next CFO.”

For more information about Brain+, please contact:

Devika Wood, CEO, E-mail: devika@brain-plus.com 

Or

Hanne Vissing Leth, CFO, Email: hanne@brain-plus.com

www.brain-plus.com

Certified Adviser

HC Andersen Capital 2 ApS

Phone: +45 28 74 66 40

E-mail: ca@hcandersencapital.dk

www.hcandersencapital.dk